Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Did Rite Aid (RAD) Stock Crash Today?

Published 09/19/2017, 03:50 AM
Updated 07/09/2023, 06:31 AM

Shares of Rite Aid (NYSE:RAD) fell more than 10% on Tuesday after Walgreens Boots (NASDAQ:WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.

In order to clear a regulatory hurdle presented by the Federal Trade Commission, Walgreens Boots said it would only buy 1,932 stores from Rite Aid. The deal is still worth a whopping $4.38 billion, but that total is a full 254 fewer stores than the companies agreed to in June.

Walgreens Boots also said that it intends to acquire three Rite Aid distribution centers located in Connecticut, Pennsylvania, and South Carolina. The exchange and transition of these distribution centers will not begin for at least another year, however.

Today’s approval looks to be the final chapter in what has been a lengthy saga involving Walgreens and Rite Aid. Earlier this year, Walgreens said it was calling off its nearly two-year operation to acquire its rival pharmacy company after numerous antitrust cases halted the deal.

Instead, Walgreens would settle for acquiring just under half of Rite Aid’s domestic stores—a figure that has obviously since been reduced. Still, the store purchase plan should help widen Walgreens Boots’ foothold in the U.S., where it also competes with the likes of CVS Health Corp. (NYSE:CVS) .

“With this process taking close to two years to come to a conclusion, we think the final outcome and the structure of the transaction were well anticipated,” an analyst at Pivotal Research Group told CNBC. “However, with each recent iteration of the transaction, the economics appear to be shifting more and more in Walgreens' favor.”

The store purchases will begin in October and will be completed in spring 2018, Walgreens said. The company also noted that the acquisitions will not have a significant impact on the company’s earnings for the fiscal year ending Aug. 31, 2018, although it expects annual synergies to reach $300 million eventually.

“We are confident in the path ahead and look forward to working together to shape the future of health care and deliver on the full potential these stores bring to our network,” Walgreens CEO Stefano Pessina said in a press release.

Want more stock market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!

4 Promising Stock Picks to Keep an Eye On

With news stories about computer hacking and identity theft becoming increasingly commonplace, the cybersecurity industry looks like a promising investment opportunity. But which stocks should you buy? Zacks just released Cybersecurity: An Investor’s Guide to Locking Down Profits to help answer this question.

This new Special Report gives you the information you need to make well-informed investment choices in this space. More importantly, it also highlights 4 cybersecurity picks with strong profit potential. Get the new Investing Guide now>>



Rite Aid Corporation (RAD): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.